Skip to main content
Beeio Honey Ltd. logo

Beeio Honey Ltd. — Investor Relations & Filings

Ticker · BHNY ISIN · IL0010823461 TA Manufacturing
Filings indexed 836 across all filing types
Latest filing 2022-04-12 Regulatory Filings
Country IL Israel
Listing TA BHNY

About Beeio Honey Ltd.

https://www.bee-io.com/

Beeio Honey Ltd. is a food technology company that has developed an industrial process for producing cultivated, bee-free honey. The company utilizes a proprietary bio-process that combines proteins produced through precision fermentation with plant-derived nectar components. This technology mimics the natural process that occurs in a bee's stomach to create a product with the taste, texture, and aroma of traditional honey. Beeio's primary goal is to offer a sustainable and eco-friendly alternative to conventional honey production, addressing issues such as bee population decline, ecological damage from commercial beekeeping, and product contamination. The company's controlled production method allows for a year-round, consistent supply of honey that is free from pesticides and antibiotics.

Recent filings

Filing Released Lang Actions
successful in producing cultured royal jelly protein with proven antibacterial properties using a bioreactor
Regulatory Filings Classification · 95% confidence The document is an 'English translation of a Hebrew immediate report' dated April 12, 2022, addressed to the Israel Securities Authority and the Tel Aviv Stock Exchange. It details a significant operational and R&D milestone: the successful production of cultured royal jelly protein using a bioreactor and proving its antibacterial properties. This type of announcement, reporting on a specific, material event or development that is not a standard periodic financial report (like 10-K or IR), typically falls under general regulatory announcements or specific event disclosures. Since it is an 'immediate report' concerning business progress rather than a change in management (MANG), director dealing (DIRS), dividend (DIV), or capital structure (CAP), it best fits the general category for regulatory filings that don't have a more specific code. Given the context of an 'immediate report' to the stock exchange about a business development, and lacking a specific code for R&D milestones, the most appropriate general category is Regulatory Filings (RNS). It is not a full financial report (10-K, IR), an earnings release (ER), or a presentation (IP).
2022-04-12 English
successful in producing cultured royal jelly protein with proven antibacterial properties using a bioreactor
Report Publication Announcement Classification · 98% confidence The document is very short (2771 characters) and explicitly states, "Attached hereto is a report on Beeio_Honey_KKR1242022_isa.pdf" and "As detailed in the attached file". It also mentions being an "English language report to Israeli corporate" filed via MAGNA for the Israel Securities Authority and Tel Aviv Stock Exchange. This structure—a brief filing that announces and attaches a separate, primary report—fits the definition of a Report Publication Announcement (RPA). It is not the full report itself (like 10-K or IR), but the announcement of its publication.
2022-04-12 English
Receiving positive international opinion and entering into the national phase for two PCT patent applications
Investor Presentation Classification · 95% confidence The document is an official update to the Israel Securities Authority and the Tel Aviv Stock Exchange regarding the progress of patent applications (PCT applications entering the national phase in the U.S.). This type of announcement, which details legal/intellectual property progress and is not a standard financial report (10-K, IR, ER), nor a management change (MANG) or dividend notice (DIV), fits best under the category for legal proceedings or significant corporate updates that don't have a dedicated code. Since it specifically concerns intellectual property protection and legal/regulatory progress related to patents, it aligns most closely with 'Legal Proceedings Report' (LTR) if interpreted broadly to include IP protection milestones, or potentially 'Regulatory Filings' (RNS) as a general update. Given the content is a specific update on patent status, which is a key corporate event, and it is not a standard financial filing, 'LTR' (Legal Proceedings Report) is a plausible fit if we consider patent prosecution a legal/regulatory process. However, since the definitions are strict, and this is a specific update on IP strategy rather than a lawsuit, the most appropriate general category for non-standard, material corporate announcements that don't fit elsewhere is 'Regulatory Filings' (RNS). The document length (4023 chars) is substantial enough that it is the report itself, not just an announcement of a report. I will classify it as RNS as it is a material, non-standard regulatory update.
2022-04-11 English
Receiving positive international opinion and entering into the national phase for two PCT patent applications
Report Publication Announcement Classification · 98% confidence The document is very short (2773 characters) and explicitly states, "Attached hereto is a report on | *As detailed in the attached file* Beeio_Honey_1142022_EDR_isa.pdf". It also mentions being an "English language report to Israeli corporate" filed via MAGNA for the Israel Securities Authority and Tel Aviv Stock Exchange. This structure—a brief notification pointing to an attached file—fits the definition of a Report Publication Announcement (RPA) rather than the full report itself (like 10-K or IR). Since it is an announcement about the publication of a report, RPA is the most appropriate classification based on Rule 2 (The 'Menu vs Meal' Rule).
2022-04-11 English
Beeio Honey Technologies Ltd. (Subsidiary) has Filed a Patent Application for Methods for the Production of Cultured Low Glycemic Index Honey
Regulatory Filings Classification · 95% confidence The document is an official update from BEEIO HONEY LTD, addressed to the Israel Securities Authority and the Tel Aviv Stock Exchange. The subject is the filing of a provisional patent application by its subsidiary for methods related to producing cultured low glycemic index honey. This type of announcement, detailing an update on intellectual property protection and R&D progress, is a specific corporate disclosure. It is not a full financial report (10-K or IR), an earnings release (ER), a management discussion (MDA), or a proxy statement (DEF 14A). Since it is a specific corporate action update regarding intellectual property and technology development, it fits best under the general category of Regulatory Filings (RNS) as it is an 'immediate report' updating the market on a significant operational/IP event, although it is not a standard financial filing. Given the options, RNS serves as the most appropriate catch-all for significant, non-standard corporate news updates that are mandatory disclosures.
2022-03-14 English
Beeio Honey Technologies Ltd. (Subsidiary) has Filed a Patent Application for Methods for the Production of Cultured Low Glycemic Index Honey
Report Publication Announcement Classification · 98% confidence The document is a short filing (2748 characters) submitted to the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). It explicitly states, "Attached hereto is a report on *As detailed in the attached file* Report.pdf". This structure, where the filing itself is merely an announcement pointing to an attached file (the actual report), strongly indicates a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. It is not the full report (like 10-K or IR), nor is it a specific announcement like a dividend (DIV) or management change (MANG).
2022-03-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.